New data from CMS show that ACOs succeed at producing quality gains and cost savings, but at least one effort begs to differ.
Key takeaways for healthcare executives from Bruno Medeiros, MD, associate professor of medicine (hematology) at the Stanford University Medical Center and director of Cancer Center Infusion Area Treatment Services at Stanford Cancer Center.
One study seeks to understand the underlying causes of racial and ethnic disparities in cancer survival. The results may be surprising.
A Physicians Foundation survey gives healthcare executives behind the scenes insight into the physician-patient relationship.
CAR-T therapies have high price tags so it’s important to understand your patient population and budget impact.
Providers are coming up short when it comes to HEDIS measures related to substance abuse. Here’s how one health plan is changing that.
Here’s how to take consumer-centricity more seriously as expectations increase.
Acute myeloid leukemia experts share promising new developments on the oncology horizon.
A new study uses population health analytics to identify potential opioid abuse, and the study findings are troubling.
Recent study findings reveal which patients are more likely to be readmitted for COPD problems, and which readmission reduction strategies might work best.